[High-dose heparin in a patient with purpura fulminans following varicella]. 1986

W Sperl, and J Parth, and J P Guggenbichler

We report on a 3 1/2 year old girl with purpura fulminans after varicella who made a complete recovery on treatment with an appropriate high-dose heparin regimen and other supporting measures. Several attempts to reduce the heparin dosage from the initial high level (85 IU/kg/hour) to the usual level (25 IU/kg/hour) were followed each time by an immediate deterioration in the clinical condition.

UI MeSH Term Description Entries
D011693 Purpura Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS). Petechiae,Purpuras
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D002644 Chickenpox A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed) Varicella,Chicken Pox
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W Sperl, and J Parth, and J P Guggenbichler
September 1968, Danish medical bulletin,
W Sperl, and J Parth, and J P Guggenbichler
June 1972, Helvetica paediatrica acta,
W Sperl, and J Parth, and J P Guggenbichler
January 1957, Archiv fur Kinderheilkunde,
W Sperl, and J Parth, and J P Guggenbichler
September 1980, La Nouvelle presse medicale,
W Sperl, and J Parth, and J P Guggenbichler
November 1966, Archives of dermatology,
W Sperl, and J Parth, and J P Guggenbichler
June 1954, Clinical proceedings - Children's Hospital of the District of Columbia,
W Sperl, and J Parth, and J P Guggenbichler
April 2009, Anales de pediatria (Barcelona, Spain : 2003),
W Sperl, and J Parth, and J P Guggenbichler
August 1966, Pediatrics,
W Sperl, and J Parth, and J P Guggenbichler
December 1973, Pediatrie,
W Sperl, and J Parth, and J P Guggenbichler
April 2019, American journal of hematology,
Copied contents to your clipboard!